With AMAP Gone, Quality Judgments In Hands of Others


When the American Medical Association shut down its physician accreditation program, AMAP, last month, several physician leaders expressed concern that the profession had lost its best chance to demonstrate efficient, high-quality care. Now, they say, health plans and others will define physician performance in their own terms.

After four years and a $12 million investment, the AMA never realized its vision for the program. The association had hoped to establish and track performance measures that would evaluate clinical processes and outcomes for AMAP-accredited physicians, but the program didn't really move beyond a physician credentialing forum.

New Jersey's medical society is particularly disappointed by the AMA's decision; one fourth of the state's physicians participated in the program. The person who led the state's AMAP operations told American Medical News that the AMA didn't adequately market the concept to payers and purchasers.

The National Committee for Quality Assurance has said it intends to develop a program that would measure quality at the physician-group level.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.